Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year

J Cyst Fibros. 2020 Nov;19(6):896-901. doi: 10.1016/j.jcf.2020.01.006. Epub 2020 Feb 7.

Abstract

Background: With the widespread introduction of newborn screening for cystic fibrosis (CF), there has been considerable emphasis on the need to develop objective markers of lung health that can be used during infancy. We hypothesised that in a newborn screened (NBS) UK cohort, evidence of airway inflammation and infection at one year would be associated with adverse structural and functional outcomes at the same age.

Methods: Infants underwent lung function testing, chest CT scan and bronchoscopy with bronchoalveolar lavage (BAL) at 1 year of age when clinically well. Microbiology cultures were also available from routine cough swabs.

Results: 65 infants had lung function, CT and BAL. Mean (SD) lung clearance index and forced expiratory volume in 0.5 s z-scores were 0.9(1.2) and -0.6(1.1) respectively; median Brody II CF-CT air trapping score on chest CT =0 (interquartile range 0-1, maximum possible score 27). Infants isolating any significant pathogen by 1 yr of age had higher LCI z-score (mean difference 0.9; 95%CI:0.4-1.4; p = 0.001) and a trend towards higher air trapping scores on CT (p = 0.06). BAL neutrophil elastase was detectable in 23% (10/43) infants in whom BAL supernatant was available. This did not relate to air trapping score on CT.

Conclusions: In this UK NBS cohort at one year of age, lung and airway damage is much milder and associations between inflammation, abnormal physiology and structural changes were at best weak, contrary to our hypothesis and previously published reports. Continued follow-up will clarify longer term implications of these very mild structural, functional and inflammatory changes.

Keywords: Airway inflammation; Chest computed tomography; Cystic fibrosis; Infant lung function; Neutrophil elastase; Newborn screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis
  • Bronchoalveolar Lavage
  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / physiopathology*
  • Disease Progression
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infections / diagnosis
  • Inflammation / diagnosis
  • Male
  • Neonatal Screening*
  • Respiratory Function Tests
  • Tomography, X-Ray Computed
  • United Kingdom

Substances

  • Biomarkers